Skip to main content
. 2020 Oct 3;23(3):592–599. doi: 10.1093/ntr/ntaa140

Table 4.

TSNAs in WB worn for 7 days in relation to child’s exposure classification

Exposure group by classification scheme (#) WB total TSNAs
n
WB total TSNAs
n (% detected)*
WB total TSNAs concentration, ng/g silicone
(median, p25–p75)
NNK
n (% detected)*
NAT
n (% detected)*
NAB
n (% detected)*
NNN
n (% detected)*
Recruitment (I)
 NS-nonexposed at recruitment 14 2 (14) 0.10 (0.0–0.10) 0 (0) 0 (0) 2 (14) 0 (0)
 EC 19 5 (26) 0.10 (0.0–0.11) 3 (16) 0 (0) 2 (11) 1 (5)
 CC 18 13 (72) 0.20 (0.05–0.53)   a 11 (61) 7 (39) 6 (33) 3 (17)
Child’s reported exposure (II)
 NS-nonexposed by caregiver report 23 6 (26) 0.05 (0.04–0.24) 3 (13) 1 (4) 3 (13) 1 (4)
 EC 14 3 (21) 0.05 (0.04–0.19)- 2 (14) 0, (0) 1 (7) 0 (0)
 EC + CC 4 3 (75) 0.09 (0.04–0.53) 2 (50) 2 (50) 1 (25) 0 (0)
 CC 9 8 (88) 0.40 (0.04–0.67)   a 7 (78) 4 (44) 5 (56) 3 (33)
Residents’ tobacco product use (III)
 NS-no use by residents 13 2 (15) 0.05 (0.04–0.13) 0 (0) 0 (0) 2 (15) 0 (0)
 EC 14 3 (21) 0.05 (0.04–0.21) 1 (7) 0 (0) 2 (14) 1 (7)
 EC + CC 13 6 (46) 0.06 (0.04–0.53) 6 (46) 3 (23) 2 (15) 1 (8)
 CC 11 9 (82) 0.25 (0.04–0.67)   a,b 7 (64) 4 (36) 4 (36) 2 (18)

Note: Bold values are significant different values (p < .05). Also note that one participant did not have a complete reported exposure variable, so n = 50 instead of n = 51 for this group.

NS = no smoking and no e-cigarette use by caregivers or residents and home smoking ban; CC = conventional cigarette; EC = electronic cigarettes; TSNAs = tobacco-specific nitrosamines; NAT = N′-nitrosoanatabine; NNN = N-nitrosonornicotine; NAB = N-nitrosoanabasine; NNK = 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; p25–p75 = 25th and 75th percentile; LOD = limit of detection (0.05 ng/g); Classification I = at recruitment, reported exposure of the child; NS = no smoking and no e-cigarette use by caregivers or residents and home smoking ban, EC exposure to EC inside; CC = exposure to CC inside; Classification II = exposure of the child in same indoor room based on report of caregiver for 7-day period; Classification III = residents reported use over 7-day period inside the home whether or not child was present. *n, (%) detected = WB that had listed compounds detected in laboratory analysis.

aSignificantly higher levels than NS (p < .01).

bSignificantly higher levels than EC (p < .01).